Literature DB >> 667822

Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (+/-)-1,2-bis(3,5-dioxopiperazin-1-y)propane (ICRF-159).

J S Lazo, D E Ingber, A C Sartorelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667822

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

Review 1.  Can cancer chemotherapy enhance the malignant behaviour of tumours?

Authors:  T J McMillan; I R Hart
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  The effectiveness of cis-platinum, cyclophosphamide and melphalan in treating disseminated tumor cells in mice.

Authors:  A Kanclerz; J D Chapman
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

3.  Enhanced experimental metastatic capacity of a murine melanoma following pre-treatment with anticancer drugs.

Authors:  T J McMillan; I R Hart
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

4.  In vivo emergence of a highly metastatic tumour cell line from a rat rhabdomyosarcoma after treatment with an alkylating agent.

Authors:  E Antoine; C Pauwels; P Verrelle; V Lascaux; M F Poupon
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

5.  Effect of stereoisomers related to ICRF-159 on metastasis of B16 melanoma.

Authors:  B S Zwilling; L B Campolito; N A Reiches; T George; D T Witiak
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.